552 792

Cited 0 times in

Cited 3 times in

Patterns of Locoregional Recurrence after Radical Cystectomy for Stage T3-4 Bladder Cancer: A Radiation Oncologist's Point of View

DC Field Value Language
dc.contributor.authorKim, Hyun Ju-
dc.contributor.authorCheon, Jae Hee-
dc.contributor.authorKim, Tae Hyung-
dc.contributor.authorYang, Gowoon-
dc.contributor.authorShin, Sang Joon-
dc.contributor.authorKim, Jin sung-
dc.contributor.authorYang, Jae Moon-
dc.contributor.authorHam, Won Sik-
dc.contributor.authorKoom, Woong Sub-
dc.date.accessioned2021-09-29T01:41:56Z-
dc.date.available2021-09-29T01:41:56Z-
dc.date.created2021-11-23-
dc.date.issued2021-07-
dc.identifier.issn0513-5796-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/184502-
dc.description.abstractPurpose: Adjuvant radiotherapy (RT) has been performed to reduce locoregional failure (LRF) following radical cystectomy for locally advanced bladder cancer; however, its efficacy has not been well established. We analyzed the locoregional recurrence patterns of post-radical cystectomy to identify patients who could benefit from adjuvant RT and determine the optimal target volume. Materials and Methods: We retrospectively reviewed 160 patients with stage >= pT3 bladder cancer who were treated with radical cystectomy between January 2006 and December 2015. The impact of pathologic findings, including the stage, lympho-vascular invasion, perineural invasion, margin status, nodal involvement, and the number of nodes removed on failure patterns, was assessed. Results: Median follow-up period was 27.7 months. LRF was observed in 55 patients (34.3%), 12 of whom presented with synchronous local and regional failures as the first failure. The most common failure pattern was distant metastasis (40%). Among LRFs, the most common recurrence site was the cystectomy bed (15.6%). Patients with positive resection margins had a significantly higher recurrence rate compared to those without (28% vs. 10%, p=0.004). The pelvic nodal recurrence rate was < 5% in pN0 patients; the rate of recurrence in the external and common iliac nodes was 12.5% in pN+ patients. The rate of recurrence in the common iliac nodes was significantly higher in pN2-3 patients than in pN0-1 patients (15.2% vs. 4.4%, p=0.04). Conclusion: Pelvic RT could be beneficial especially for those with positive resection margins or nodal involvement after radical cystectomy. Radiation fields should be optimized based on the patient-specific risk factors.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherYonsei University-
dc.relation.isPartOfYonsei Medical Journal-
dc.relation.isPartOfYONSEI MEDICAL JOURNAL-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titlePatterns of Locoregional Recurrence after Radical Cystectomy for Stage T3-4 Bladder Cancer: A Radiation Oncologist&apos;s Point of View-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Radiation Oncology (방사선종양학교실)-
dc.contributor.googleauthorKim, Hyun Ju-
dc.contributor.googleauthorCheon, Jae Hee-
dc.contributor.googleauthorKim, Tae Hyung-
dc.contributor.googleauthorYang, Gowoon-
dc.contributor.googleauthorShin, Sang Joon-
dc.contributor.googleauthorKim, Jin sung-
dc.contributor.googleauthorYang, Jae Moon-
dc.contributor.googleauthorHam, Won Sik-
dc.contributor.googleauthorKoom, Woong Sub-
dc.identifier.doi10.3349/ymj.2021.62.7.569-
dc.relation.journalcodeJ02813-
dc.identifier.eissn1976-2437-
dc.subject.keywordUrinary bladder neoplasms-
dc.subject.keywordadjuvant radiotherapy-
dc.subject.keywordcystectomy-
dc.subject.keywordrecurrence-
dc.contributor.alternativeNameKoom, Woong Sub-
dc.contributor.affiliatedAuthorCheon, Jae Hee-
dc.contributor.affiliatedAuthorYang, Gowoon-
dc.contributor.affiliatedAuthorShin, Sang Joon-
dc.contributor.affiliatedAuthorKim, Jin sung-
dc.contributor.affiliatedAuthorYang, Jae Moon-
dc.contributor.affiliatedAuthorHam, Won Sik-
dc.contributor.affiliatedAuthorKoom, Woong Sub-
dc.identifier.scopusid2-s2.0-85109027046-
dc.identifier.wosid000669606500001-
dc.citation.volume62-
dc.citation.number7-
dc.citation.startPage569-
dc.citation.endPage576-
dc.identifier.bibliographicCitationYonsei Medical Journal, Vol.62(7) : 569-576, 2021-07-
dc.identifier.rimsid71707-
dc.type.rimsART-
dc.description.journalClass1-
dc.description.journalClass1-
dc.subject.keywordAuthorUrinary bladder neoplasms-
dc.subject.keywordAuthoradjuvant radiotherapy-
dc.subject.keywordAuthorcystectomy-
dc.subject.keywordAuthorrecurrence-
dc.subject.keywordPlusUROTHELIAL CARCINOMA-
dc.subject.keywordPlusRISK STRATIFICATION-
dc.subject.keywordPlusPOSTOPERATIVE RADIOTHERAPY-
dc.subject.keywordPlusBILHARZIAL BLADDER-
dc.subject.keywordPlusFREE SURVIVAL-
dc.subject.keywordPlusFAILURE-
dc.subject.keywordPlusOUTCOMES-
dc.type.docTypeArticle-
dc.identifier.kciidART002725082-
dc.description.isOpenAccessY-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.description.journalRegisteredClasskci-
dc.relation.journalWebOfScienceCategoryMedicine, General & Internal-
dc.relation.journalResearchAreaGeneral & Internal Medicine-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Radiation Oncology (방사선종양학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Radiology (영상의학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Urology (비뇨의학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.